Lung cancer (clinical) NBPDS
Identifying and definitional attributes
|Metadata item type:||Data Set Specification|
|Registration status:||Health, Standard 14/05/2015|
|DSS type:||Data Set Specification (DSS)|
The purpose of the Lung cancer (clinical) National best practice data set (NBPDS) is to define data standards for the national collection of lung cancer clinical data so that data collected is consistent and reliable. Collection of this data set is not mandated but it is recommended as best practice if clinical cancer data are to be collected. It will facilitate more consistent data collection while enabling individual treatment centres or health service areas to develop data extraction and collection processes and policies that are appropriate for their service settings.
The Lung cancer (clinical) NBPDS is used in conjunction with the Cancer (clinical) NBPDS. Mandatory reporting regulations have enabled population-based cancer registries in Australia to collect standard information on all incident cases of cancer apart from non-melanoma skin cancers, from which incidence, mortality and overall survival have been determined and trends monitored. The Cancer (Clinical) NBPDS provides a framework for the collection of more detailed and comprehensive clinical data such as stage of cancer at diagnosis, other prognostic characteristics, cancer treatment and patient outcomes.
The Lung cancer (clinical) NBPDS will support prospective data collection from the time a person with cancer symptoms is referred or first presents to a hospital or specialist through the entire duration of their illness.
The definitions used in this data set are designed to capture the provision of cancer care on a day-to-day level. They relate to the cancer care pathway and the need to optimise care by correctly diagnosing, evaluating and managing patients with cancer. In addition, end-points and patterns of care can be monitored to understand both the appropriateness and effectiveness of cancer care.
The data elements specified provide a framework for:
They will facilitate the aggregation of data across different treatment centres.
The underlying long-term goal is to provide data support to improve outcomes for patients by increasing the quality and length of life. For example, a comparison of the actual management of patients with best practice guidelines may identify shortfalls in treatment and limitations in access to treatment modalities for some patients.
Collection and usage attributes
|Guide for use:|
The data elements in the Lung cancer (clinical) NBPDS with obligations described as mandatory or conditional for collection are recommended as best practice, while the data items described as optional are for collection at the discretion of the treating centre and may be contingent, for example, on the availability of resources.
This data set is primarily directed at the clinical and clinical epidemiological use of cancer data. Treatment centres such as hospitals, radiotherapy centres and cancer specialist practices are the settings in which implementation of the Lung cancer (clinical) NBPDS should be considered. The data set can also be used by a wider range of health and health-related establishments that create, use, or maintain records on health-care clients.
Source and reference attributes
|Related metadata references:|
See also Cancer (clinical) NBPDS Health, Standard 14/05/2015
Supersedes Lung cancer (clinical) DSS Health, Superseded 14/05/2015